Cyteir TherapeuticsCYTT
13F holders, Q1 2024 (March 31)4holders
$3.01avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Cyteir Therapeutics Inc. (CYTT) in their 13F filings. The largest holders were BML Capital Management, LLC ($11.0M), Acadian Asset Management LLC ($77K) and Boston Family Office LLC ($73K).
- Company
- Cyteir Therapeutics Inc.
- CUSIP
- 23284P103
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $77K |
| Exits | 36 | $28.9M |
Ownership 4 holders
| BML Capital Management, LLC | 7.36% | Add +12.4% | 3,654,053 | $11.0M |
| Acadian Asset Management LLC | 0.00% | New | 26,319 | $77K |
| Boston Family Office LLC | 0.01% | No change | 24,197 | $73K |
| Lindbrook Capital, LLC | 0.00% | No change | 2,006 | $6K |
"% of holder's portfolio" is CYTT's weight in each manager's 13F, not the share of Cyteir Therapeutics Inc. the manager owns.